Barclays’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,643
| Closed | -$42K | – | 5052 |
|
|
2022
Q1 | $42K | Sell |
7,643
-48,104
| -86% | -$264K | ﹤0.01% | 4072 |
|
|
2021
Q4 | $540K | Buy |
55,747
+35,566
| +176% | +$345K | ﹤0.01% | 2499 |
|
|
2021
Q3 | $360K | Buy |
20,181
+14,173
| +236% | +$253K | ﹤0.01% | 2739 |
|
|
2021
Q2 | $146K | Sell |
6,008
-24,461
| -80% | -$594K | ﹤0.01% | 3005 |
|
|
2021
Q1 | $807K | Buy |
30,469
+9,898
| +48% | +$262K | ﹤0.01% | 2411 |
|
|
2020
Q4 | $157K | Sell |
20,571
-7,106
| -26% | -$54.2K | ﹤0.01% | 2811 |
|
|
2020
Q3 | $140K | Sell |
27,677
-3,543
| -11% | -$17.9K | ﹤0.01% | 2894 |
|
|
2020
Q2 | $187K | Buy |
31,220
+15,535
| +99% | +$93.1K | ﹤0.01% | 2843 |
|
|
2020
Q1 | $70K | Sell |
15,685
-19,315
| -55% | -$86.2K | ﹤0.01% | 2958 |
|
|
2019
Q4 | $333K | Buy |
35,000
+13,965
| +66% | +$133K | ﹤0.01% | 2913 |
|
|
2019
Q3 | $164K | Sell |
21,035
-8,778
| -29% | -$68.4K | ﹤0.01% | 3148 |
|
|
2019
Q2 | $468K | Buy |
29,813
+18,982
| +175% | +$298K | ﹤0.01% | 2748 |
|
|
2019
Q1 | $195K | Buy |
10,831
+10,631
| +5,316% | +$191K | ﹤0.01% | 3047 |
|
|
2018
Q4 | $3K | Sell |
200
-4,355
| -96% | -$65.3K | ﹤0.01% | 3880 |
|
|
2018
Q3 | $109K | Buy |
+4,555
| New | +$109K | ﹤0.01% | 3369 |
|